Justice Department Opens Investigation Into Fluvirin
This article was originally published in The Pink Sheet Daily
Executive Summary
Chiron is responding to a grand jury subpoena from the New York City U.S. Attorney's Office regarding Fluvirin
You may also be interested in...
Chiron Issues Fourth Quarter, Full-Year Earnings Restatement
The restatement is the result of improper revenue recognition of traveler vaccines in the second quarter and later periods, Chiron says. The company also reports lower flu vaccine sales as part of the restatement.
Chiron Issues Fourth Quarter, Full-Year Earnings Restatement
The restatement is the result of improper revenue recognition of traveler vaccines in the second quarter and later periods, Chiron says. The company also reports lower flu vaccine sales as part of the restatement.
CDC, Distributors Could Sue Chiron For Failing To Supply Fluvirin
Centers for Disease Control & Prevention issues a notice asking why Chiron should not be held in default for failing to supply Fluvirin to the government, the company says in an SEC filing. Fluvirin distributors have also suggested that they should be compensated under their contracts for the 2004-2005 season.